Filing Details
- Accession Number:
- 0001179110-14-006389
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-03 14:44:13
- Reporting Period:
- 2014-04-01
- Filing Date:
- 2014-04-03
- Accepted Time:
- 2014-04-03 14:44:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 64670 | Medtronic Inc | MDT | Electromedical & Electrotherapeutic Apparatus (3845) | 410793183 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1290170 | Lee Gary Ellis | 710 Medtronic Pkwy Ms Lc300 Minneapolis MN 55432 | Srvp & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-04-01 | 4,246 | $50.46 | 179,201 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-04-01 | 4,246 | $61.48 | 174,955 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-04-01 | 4,246 | $0.00 | 4,246 | $50.46 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2004-04-30 | 2014-04-30 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,986 | Indirect | 401(k) |
| Common Stock | 7,461 | Indirect | ESOP |
Footnotes
- The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $61.47 to $61.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
Billionaire Hedge Funds
